Trust Co. of Vermont purchased a new position in Becton, Dickinson and Company (NYSE:BDX – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 32,999 shares of the medical instruments supplier’s stock, valued at approximately $4,994,000.
Several other institutional investors and hedge funds also recently bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Becton, Dickinson and Company in the second quarter valued at $107,392,000. Beverly Hills Private Wealth LLC purchased a new position in shares of Becton, Dickinson and Company during the 2nd quarter worth about $3,353,000. OneDigital Investment Advisors LLC purchased a new position in shares of Becton, Dickinson and Company during the 2nd quarter worth about $1,282,000. Plato Investment Management Ltd bought a new position in Becton, Dickinson and Company during the 2nd quarter valued at about $1,728,000. Finally, Bell Investment Advisors Inc bought a new position in Becton, Dickinson and Company during the 2nd quarter valued at about $29,000. 86.97% of the stock is owned by hedge funds and other institutional investors.
Becton, Dickinson and Company Price Performance
Shares of BDX stock opened at $182.39 on Tuesday. The company has a market capitalization of $50.26 billion, a P/E ratio of 54.94, a P/E/G ratio of 12.93 and a beta of 0.19. The company’s 50-day simple moving average is $158.48 and its two-hundred day simple moving average is $161.26. Becton, Dickinson and Company has a one year low of $127.59 and a one year high of $187.35. The company has a debt-to-equity ratio of 0.55, a current ratio of 0.87 and a quick ratio of 0.51.
Becton, Dickinson and Company Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 9th will be paid a dividend of $1.05 per share. The ex-dividend date is Wednesday, September 9th. This represents a $4.20 annualized dividend and a dividend yield of 2.3%. Becton, Dickinson and Company’s dividend payout ratio (DPR) is currently 126.51%.
Insider Activity
In other Becton, Dickinson and Company news, CEO Thomas E. Polen, Jr. sold 4,152 shares of the stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $185.00, for a total transaction of $768,120.00. Following the transaction, the chief executive officer directly owned 110,163 shares in the company, valued at $20,380,155. This represents a 3.63% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Roland Goette sold 2,438 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $180.84, for a total transaction of $440,887.92. Following the transaction, the executive vice president directly owned 14,856 shares in the company, valued at $2,686,559.04. This trade represents a 14.10% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 11,779 shares of company stock worth $1,974,669. Company insiders own 0.40% of the company’s stock.
Wall Street Analyst Weigh In
BDX has been the subject of several analyst reports. Evercore set a $180.00 price objective on shares of Becton, Dickinson and Company in a research note on Monday, July 6th. Stifel Nicolaus set a $195.00 target price on Becton, Dickinson and Company in a research note on Friday, August 7th. Piper Sandler increased their price target on Becton, Dickinson and Company from $161.00 to $175.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Citigroup reissued a “buy” rating on shares of Becton, Dickinson and Company in a research note on Thursday. Finally, Royal Bank Of Canada boosted their price objective on Becton, Dickinson and Company from $180.00 to $190.00 and gave the company a “sector perform” rating in a report on Thursday, August 13th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $185.67.
Check Out Our Latest Stock Analysis on Becton, Dickinson and Company
About Becton, Dickinson and Company
Becton, Dickinson and Company (BDX) is a global medical technology company that develops, manufactures and sells a broad range of medical devices, instrument systems and reagents. BD’s products are used by healthcare institutions, clinical laboratories, life science researchers and the pharmaceutical industry to enable safe, effective delivery of care, specimen collection and diagnostic testing. The company’s operations span multiple business areas focused on medical devices, life sciences research tools and interventional technologies.
BD’s product portfolio includes single-use medical devices such as syringes, needles, needlesafety and injection systems, infusion therapy and medication management solutions, as well as vascular access, urology and oncology devices acquired through its interventional business.
Featured Stories
- Five stocks we like better than Becton, Dickinson and Company
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX – Free Report).
Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.
